Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study - Quiz - MDSpire

Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study

  • By

  • Gregor Duwe

  • Melanie Schmitteckert

  • Maximilian Haack

  • Peter Sparwasser

  • Robert Dotzauer

  • Anita Thomas

  • Igor Tsaur

  • Maximilian Peter Brandt

  • Martin Kurosch

  • Rene Mager

  • Axel Haferkamp

  • Katharina Boehm

  • Thomas Höfner

  • May 6, 2024

  • 0 min

Share

Original Source(s)

Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study

  • by Gregor Duwe, Melanie Schmitteckert, Maximilian Haack, Peter Sparwasser, Robert Dotzauer, Anita Thomas, Igor Tsaur, Maximilian Peter Brandt, Martin Kurosch, Rene Mager, Axel Haferkamp, Katharina Boehm, Thomas Höfner

  • May 6, 2024

Related Content

Impact of the PI-QUAL MRI quality score on histopathological up-staging from MRI fusion biopsy to final prostatectomy specimen

Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging

T2 mapping for the characterization of prostate lesions